Building confidence at the edge through embedded trust anchors

Tern plc

As digital infrastructure expands across sectors such as healthcare, energy, and manufacturing, the cost of weak or default identities is no longer theoretical. Every unverified connection introduces potential disruption, regulatory risk, and in the most critical environments, threats to safety itself.

Device Authority has placed this foundational challenge at the centre of its Zero Trust strategy. Through its KeyScaler® platform, the company has redefined how identity and policy can be embedded at the edge, directly within the manufacturing and onboarding stages of connected devices. By automating the creation of strong, unique identities tied to secure hardware or generated dynamically where hardware roots of trust do not exist, the system removes the manual processes that often lead to configuration errors and scalability issues. This enables manufacturers and operators to secure fleets of devices from the instant they connect, without human intervention or bottlenecks.

When partnered with Olympus, KeyScaler allows trust anchors to feed directly into enterprise identity and access management systems, ensuring that every device remains under continuous policy governance. Context, behaviour, and health signals can trigger automated responses, from restricted access to complete revocation, ensuring that any anomaly is addressed instantly and proportionately.

Importantly, Device Authority’s approach also acknowledges industrial reality. Many enterprises must work with extensive brownfield environments where legacy assets lack the modern security hardware of new devices. For these cases, KeyScaler’s Dynamic Device Key Generation and Trust on First Use models create strong, software-based identities that can later be reinforced through re-enrolment or attestation.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Novo Nordisk deal puts focus on next generation of oral GLP-1 treatments

Novo Nordisk secures rights to Hengrui's investigational HRS-1596 in a potential $2.6bn deal, targeting the development of once-weekly oral...

Device Authority warns supermarket freezer cyberattack exposes connected device security risks

Device Authority warns that a cyberattack affecting around 700 French supermarkets exposes security weaknesses in connected industrial equipment and...

Breast cancer research highlights importance of patient intelligence in pharma

Talking Medicines highlights how AI-powered patient intelligence can help pharmaceutical companies understand breast cancer treatment experiences and identify unmet...

GLP-1 drugs linked to emerging research into mental health and addiction

Research into GLP-1 medicines is expanding beyond weight loss, with studies examining potential links to depression, cognitive function, alcohol...

Talking Medicines examines emerging links between GLP-1 drugs and mental health

Researchers are investigating the potential links between GLP-1 medicines and mental health, with early findings prompting further studies into...

Tern invests £78,000 in Device Authority through 8% convertible loan notes

Tern Plc has committed approximately £78,000 to new convertible loan notes issued by Device Authority, which carry 8% annual...

Search